Solanezumab

Tax included
Solanezumab is a humanized monoclonal IgG1 antibody directed against the mid-domain of the amyloid-β (Aβ) peptide. Solanezumab has the potential for the research of Alzheimer’s disease.
MedChemExpress 
HY-P99317

Data sheet

Size
Multiple sizes
Reactivity
Amyloid-β
Application
Neuroscience-Neurodegeneration
CAS
955085-14-0